Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALNY | AMGN | GILD | VRTX | BIIB |
| Company | Alnylam Pharmaceuticals | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 151.81 | 312.89 | 64.72 | 420.67 | 222.76 |
| High | 151.81 | 314.89 | 66.20 | 423.32 | 223.95 |
| Low | 148.75 | 309.82 | 64.67 | 417.50 | 220.01 |
| Last | 150.47 | 310.15 | 65.96 | 422.78 | 221.50 |
| Change | -0.90 | -2.71 | +1.38 | +3.79 | -1.25 |
| % Change | -0.59% | -0.87% | +2.14% | +0.90% | -0.56% |
| Volume | 322,700 | 2,611,800 | 8,733,101 | 1,064,500 | 655,100 |
| 20-Day Average Volume | 468,690 | 2,930,860 | 7,614,370 | 1,107,775 | 1,327,535 |
| Previous Close | 151.37 | 312.86 | 64.58 | 418.99 | 222.75 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 147.78 | 281.61 | 65.99 | 401.94 | 207.57 |
| 20-Day Raw Stochastic | 62.86% | 79.89% | 39.52% | 91.71% | 92.90% |
| 20-Day Relative Strength | 49.60% | 65.95% | 39.82% | 62.31% | 58.34% |
| Weighted Alpha | -26.42 | +34.03 | -19.29 | +22.92 | -26.00 |
| Today's Opinion | 56% Sell | 56% Buy | 100% Sell | 56% Buy | 56% Sell |
| Previous Opinion | 56% Sell | 56% Buy | 100% Sell | 56% Buy | 56% Sell |
| Last Month's Opinion | 80% Sell | 40% Sell | 100% Sell | 24% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.22% since 05/03/24 | -0.37% since 05/03/24 | +1.82% since 05/03/24 | +5.41% since 05/03/24 | +1.83% since 05/03/24 |
| Low | 148.75 on 05/10/24 | 297.52 on 05/06/24 | 64.34 on 05/06/24 | 394.03 on 05/07/24 | 216.08 on 05/07/24 |
| High | 155.49 on 05/08/24 | 314.89 on 05/10/24 | 66.20 on 05/10/24 | 425.65 on 05/08/24 | 223.95 on 05/10/24 |
| 1-Month | |||||
| %Chg | -1.27% since 04/10/24 | +16.40% since 04/10/24 | -3.17% since 04/10/24 | +6.34% since 04/10/24 | +9.90% since 04/10/24 |
| Low | 141.98 on 04/25/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 155.49 on 05/08/24 | 322.60 on 05/03/24 | 69.03 on 04/11/24 | 425.65 on 05/08/24 | 223.95 on 05/10/24 |
| 3-Month | |||||
| %Chg | -11.50% since 02/09/24 | +6.54% since 02/09/24 | -10.47% since 02/09/24 | -0.03% since 02/09/24 | -8.08% since 02/09/24 |
| Low | 141.98 on 04/25/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 171.57 on 02/12/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 437.00 on 02/27/24 | 244.95 on 02/12/24 |
| 6-Month | |||||
| %Chg | -7.05% since 11/10/23 | +16.03% since 11/10/23 | -13.12% since 11/10/23 | +13.15% since 11/10/23 | -1.46% since 11/10/23 |
| Low | 141.98 on 04/25/24 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 341.90 on 11/16/23 | 189.44 on 04/19/24 |
| High | 199.38 on 01/09/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 19,147,092 | 167,829,040 | 80,407,072 | 108,121,632 | 32,431,732 |
| Shares Outstanding, K | 126,492 | 536,435 | 1,245,077 | 258,053 | 145,597 |
| Annual Sales | 1,828,290,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | -440,240,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 494,330,000 | 7,447,000,000 | 6,686,000,000 | 2,517,700,000 | 2,290,500,000 |
| Last Quarter Net Income | -65,940,000 | -113,000,000 | -4,170,000,000 | 968,800,000 | 393,400,000 |
| 60-Month Beta | 0.41 | 0.60 | 0.22 | 0.39 | -0.01 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 05/02/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 4.76 on 05/06/24 | 3.67 on 04/24/24 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 04/25/24 | 05/06/24 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.50 | 16.11 | 27.81 | 14.65 |